HomeCompanies › CBIO

CRESCENT BIOPHARMA, INC.

Most recent annual filing: 2026-02-26

Pipeline (10 active programs)

CR-001

SKB118
Protein Target: PD-1, VEGF

CR-003

SKB105
Protein Target: ITGB6
  • Undisclosed indication Phase 1 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Biotech Distilled coverage (1)

Articles open on Substack. Some deep dives are subscriber-only.